ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Hippocratic AI Receives Investment From NVentures to Build Generative AI Healthcare Agents

Investment follows technical collaboration on large language models for healthcare.

Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced it has received an investment from NVentures, NVIDIA’s venture capital arm in its recently closed extended Series A round. NVentures, along with Greycroft and Leo Shapiro of 7Wire Ventures, contributed a combined total of an additional $17 million to the round, bringing the total invested in the company to $137 million. The first close of the Series A round was co-led by Premji Invest and General Catalyst with participation from SV Angel and Memorial Hermann Health System as well as existing investors Andreessen Horowitz (a16z) Bio + Health, Cincinnati Children’s, WellSpan Health, and Universal Health Services (UHS) at a $500 million valuation.

Hippocratic AI’s collaboration with NVIDIA is centered on cutting-edge technological advancements. Hippocratic AI is leveraging NVIDIA NIM microservices to scale its production platform to deliver low-latency and long-context conversational capabilities. The collaboration, launched at the NVIDIA GTC global AI conference earlier this year, includes several techniques tailored for real-time, long-context conversational AI, including prefix caching, speculative decoding, and prefill/decode disaggregation. In addition, Hippocratic AI, powered by NVIDIA technologies, is advancing medical domain specialization in LLMs through custom automated speech recognition (ASR) technology, fine-tuned to meet the needs of clinician-patient interactions.

“NVIDIA is an ideal collaborator to help us achieve our vision of delivering healthcare abundance,” said Munjal Shah, co-founder and CEO of Hippocratic AI. “Our deep technical collaboration has helped us to build an LLM with extremely low latency leading to more empathetic inference capabilities. Their venture capital arm’s investment in our company demonstrates our shared interest in harnessing the power of generative AI to revolutionize healthcare.”

“Generative AI will expand the healthcare industry and its ability to serve the growing demands of patient care, and Hippocratic AI is putting the technology to work to increase access to healthcare,” said Kimberly Powell, vice president of healthcare at NVIDIA. “The company’s safety-focused approach uses advanced NVIDIA technologies to make personalized, real-time patient interactions more natural and capable, helping build trust among patients and clinicians alike.”

About Hippocratic AI

Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and NVIDIA. Hippocratic AI has received a total of $137 million in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, SV Angel, NVentures, and Greycroft. For more information on Hippocratic AI: www.HippocraticAI.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.